Search results for "U.S. Phase 3 clinical trial"

Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial

Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial

Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the Phase 1b clinical trial for its...